1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Canada Generic Drug Market: Introduction
4.1 What are Generics?
4.2 Unbranded and Branded Generics
4.3 Authorized Generics
4.4 Specialty Generics
5 Why is the Generic Drug Market So Lucrative in Canada
5.1 Blockbuster Drugs Facing Patent Expiration
5.2 Substantial Price Difference Between Branded and Generic Drugs
5.3 Government Incentives
5.4 Savings for Drug Purchasers
5.5 Biosimilars
5.6 Ageing Population and Increasing Prevalence of Life Style Diseases
6 Global Generic Drug Market
6.1 Generic Drug Market Performance
6.1.1 Value Trends
6.1.2 Volume Trends
6.2 Market Breakup by Country
6.3 Most Prescribed Generic and Branded Drugs
6.4 Market Forecast
7 Canada Generic Drug Market
7.1 Canada Pharmaceutical Market Performance
7.1.1 Value Trends
7.1.2 Volume Trends
7.1.3 Market by Type
7.1.4 Market Forecast
7.2 Canada Generic Drug Market Performance
7.2.1 Value Trends
7.2.2 Volume Trends
7.2.3 Impact of COVID-19
7.2.4 Market Forecast
8 SWOT Analysis
8.1 Overview
8.2 Strengths
8.3 Weaknesses
8.4 Opportunities
8.5 Threats
9 Value Chain Analysis
9.1 Research and Development
9.2 Manufacturing
9.3 Marketing
9.4 Distribution
10 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
11 Porter’s Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Canada Generic Drug Market: Competitive Landscape
12.1 Canada Generic Drug Market – Competitive Structure
12.2 Canada Generic Drug Market – Sales Breakup of Key Players
12.3 Canada Generics Distribution – Breakup by Channel
12.4 Canada Generic Drug Market – Average Retail Price Per Prescription (Generic vs. Branded)
13 Canada Generic Drug Market: Key Success Factors
14 Canada Generic Drug Market: Road Blocks
15 Canada Generic Drug Market: Regulatory Framework
15.1 Overview of Pharmaceutical Regulations
15.2 Pre-Market Drug Submission Requirements for Generic Drugs
15.3 Review Process for Generic Drugs
15.4 Generic Drug Approval and Declaration of Its Bioequivalence
15.5 Other Important Consideration
16 Generic Drug Manufacturing Process
16.1 Manufacturing Process
16.2 Raw Material Requirements
16.3 Raw Materials Pictures
16.4 Land and Construction Requirements
16.5 Machinery and Infrastructure Requirements
16.6 Machinery Pictures
16.7 Plant Layout
16.8 Packaging Requirements
16.9 Utility Requirements
16.10 Manpower Requirements
17 Canada Generic Drug Market - Key Company Profiles
17.1 Apotex Inc.
17.2 Mylan Pharmaceuticals ULC
17.3 Pharmascience Inc.
17.4 Sandoz AG
17.5 Sun Pharma Industries Ltd.
17.6 Teva Pharmaceutical Industries Limited
List of Figures
Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: Canada: Patent Expiry Exposure (in Billion US$)
Figure 4: Canada: Savings from Generic Drugs (in Billion US$), 2018-2023
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Units), 2018-2023
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2023
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2023
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2024-2032
Figure 11: Canada: Pharmaceutical Market: Sales Value (in Billion US$), 2018-2023
Figure 12: Canada: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 13: Canada: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2018-2023
Figure 14: Canada: Pharmaceutical Market Forecast: Sales Volume (in Million Prescriptions), 2024-2032
Figure 15: Canada: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2018 and 2023
Figure 16: Canada: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2018 and 2023
Figure 17: Canada: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 18: Canada: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 19: Canada: Generic Drug Market: Sales Volume (in Million Prescriptions), 2018-2023
Figure 20: Canada: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2024-2032
Figure 21: Canada: Generic Drug Market: Sales Breakup of Key Players (in %)
Figure 22: Canada: Generic Drug Market: Average Retail Price Per Prescription (Generics vs. Branded- in US$ Per Prescription), 2018-2023
Figure 23: Canada: Generic Drug Industry: SWOT Analysis
Figure 24: Canada: Generic Drug Industry: Value Chain Analysis
Figure 25: Pricing Trends and Profit Margins at Various Levels of Supply Chain
Figure 26: Canada: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 27: Canada: Generic Drug Market: Regulatory Framework for Generic Drugs
Figure 28: Generic Drug Manufacturing: Detailed Process Flow
Figure 29: Generic Drug Manufacturing: Plant Layout
List of Tables
Table 1: Canada: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: Global: Generic Drug Market: Sales Volume and Growth of Major Markets, 2023
Table 3: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2023
Table 4: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2023
Table 5: Canada: Distribution of Generic Drugs: Breakup by Channel (in %), 2023
Table 6: Generic Drug Manufacturing Plant: Raw Material Requirements
Table 7: Generic Drug Manufacturing Plant: Land and Construction Requirements
Table 8: Generic Drug Manufacturing Plant: Machinery Requirements
Table 9: Generic Drug Manufacturing Plant: Utility Requirements
Table 10: Generic Drug Manufacturing Plant: Manpower Requirements
Table 11: Generic Drug Manufacturing Plant: Packaging Requirements